Your Article Summary
See Latest ArticlesClinical implications of hypoxia inducible factor in renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations, 06/29/09
Smaldone MC et al. - In a review of the clinical implications of hypoxia inducible factor (HIF) in renal cell carcinoma (RCC), this report provides a directed review of recent discoveries defining the role of HIF in renal tumorigenesis and their relevance to clinical advances in targeted therapy for advanced RCC.
Methods- Management of RCC has made considerable strides in the past decade, due in large part to identification of the von Hippel Lindau (VHL) tumor suppressor as a negative regulator of HIF-α protein expression.
- Stabilization of HIF-α appears to be critical for renal tumorigenesis, and is observed even in VHL-independent RCC.
- An understanding of the pathways that regulate expression and activation of the different HIF-α isoforms is key to delineating the mechanism of renal transformation and for development of novel therapeutics.
- A number of agents targeting HIF-α or its transcriptionally-regulated genes have shown promise in treatment of RCC.
- More effective treatment strategies are still needed.
Related Articles
The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha in human rheumatoid arthritis fibroblast-like synoviocyte
Rheumatology International, 10/30/09
Relevance Score: 83%
Neuroprotective effect of combined hypoxia-induced VEGF and bone marrow-derived mesenchymal stem cell treatment
Child's Nervous System, 11/20/09
Relevance Score: 80%
Involvement of hypoxia-inducible factor-1 HiF(1[alpha]) in IgE-mediated primary human basophil responses
European Journal of Immunology, 11/18/09
Relevance Score: 80%
Hypoxia inducible factor-1alpha induction by tumour necrosis factor-alpha, but not by toll-like receptor agonists, modulates cellular respiration in cultured human hepatocytes
Liver International, 10/08/09
Relevance Score: 80%
c-Jun Protects Hypoxia-Inducible Factor-1 from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner
Cancer Research, 10/05/09
Relevance Score: 79%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Birt-Hogg-Dube syndrome: diagnosis and management
The Lancet Oncology, 12/04/09
Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram
Journal of Clinical Oncology, 12/04/09
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
European Urology, 12/04/09